Key drivers for each region include: for North America, adoption of point-of-care blood analysis systems, policies supporting personalized medicine, and infrastructure advancements; for Europe, ecosystem maturity in terms of research and development, investments in digital health, and regulatory frameworks; for Asia Pacific, demographics and rising demand for blood analysis systems, government initiatives to improve healthcare access, and technological advancements; for Latin America, expanding healthcare access, increasing investments in medical devices, and growing awareness of blood-related diseases; and for Middle East & Africa, growing healthcare expenditure, infrastructure development, and rising prevalence of chronic diseases.